| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |